Us Bancorp \De\ Black Diamond Therapeutics, Inc. Transaction History

Us Bancorp \De\

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$5.18 - $8.48 $1,963 - $3,213	-379 Reduced 35.13%	700 $4,000
Q3 2021 Nov 10, 2021	BUY	$8.46 - $12.42 $3,206 - $4,707	379 Added 54.14%	1,079 $9,000
Q3 2020 Nov 10, 2020	BUY	$26.17 - $43.07 $7,851 - $12,921	300 Added 75.0%	700 $21,000
Q2 2020 Aug 07, 2020	BUY	$22.3 - $44.8 $8,920 - $17,920	400 New	400 $17,000

117

48.8M

1.84M

1.93M

Ticker BDTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,339,500
Market Cap $79.2M
Description
Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epide...

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

Stay updated on Us Bancorp \De\ with notifications on news.